Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. Hospitals

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3837-3842

  Moland, Ellen Smith ^a   Black, Jennifer A ^a   Ourada, Jason ^a   Reisbig, Mark D ^a   Hanson, Nancy D ^a   Thomson, Kenneth S ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; DNA; ERTAPENEM; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; AMPC BETA LACTAMASES; AMPC BETA-LACTAMASES; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLINICAL LABORATORY; HOSPITAL INFECTION; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES; BIOSYNTHESIS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE;

BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; UNITED STATES;

EID: 0036895367     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3837-3842.2002     Document Type: Article

References (38)

1. Afzal-Shah, M., H. E. Villar, and D. M. Livermore. 1999. Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina. J. Antimicrob. Chemother. 43:127-131.
2. Barnaud, G., G. Arlet, C. Verdet, O. Gaillot, P. H. Lagrange, and A. Philippon. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42:2352-2358.
3. Bauernfeind, A., Y. Chong, and K. Lee. 1998. Plasmid-encoded AmpC beta-lactamases: How far have we gone 10 years after the discovery? Yonsei Med. J. 39:520-525.
4. Bauernfeind, A., Y. Chong, and S. Schweighart. 1989. Extended broad-spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316-321.
5. Bradford, P. A. 2001. What's new in β-lactamases? Curr. Infect. Dis. Rep. 3:13-19.
6. Brun-Buisson, C., P. Legrand, A. Philippon, F. Montravers, M. Ansquer, and J. Duval. 1987. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii:302-306.
7. Bush, K. 1998. Metallo-beta-lactamases: A class apart. Clin. Infect. Dis. 27(Suppl. 1):S48-S53.
8. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
9. Casellas, J. M., and M. Goldberg. 1989. Incidence of strains producing extended spectrum β-lactamases in Argentina. Infection 17:434-436.
10. Coudron, P. E., E. S. Moland, and K. S. Thomson. 2000. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 38:1791-1796.
11. Felici, A., and G. Amicosante. 1995. Kinetic analysis of extension of substrate specificity with Xanthomonas maltophilia, Aeromonas hydrophila, and Bacillus cereus metallo-β-lactamases. Antimicrob. Agents Chemother. 39:192-199.
12. Fortineau, N., L. Poirel, and P. Nordmann. 2001. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J. Antimicrob. Chemother. 47:207-210.
13. Hanson, N. D., E. S. Moland, A. Hossain, S. A. Neville, I. B. Gosbell, and K. S. Thomson. 2002. Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases. J. Antimicrob. Chemother. 49:1011-1014.
14. Jacoby, G., P. Han, and J. Tran. 1997. Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens. Antimicrob. Agents Chemother. 41:1830-1831.
15. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 35:1697-1704.
16. Karas, J. A., D. G. Pillay, D. Muckart, and A. W. Sturm. 1996. Treatment failure due to extended spectrum β-lactamase. J. Antimicrob. Chemother. 37:203-204.
17. Livermore, D. M., K. J. Oakton, M. W. Carter, and M. Warner. 2001. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent β-lactamases. Antimicrob. Agents Chemother. 45:2831-2837.
18. Livermore, D. M., and N. Woodford. 2000. Carbapenemases: A problem in waiting? Curr. Opin. Microbiol. 3:489-495.
19. Masuda, G., S. Tomioka, and M. Hasegawa. 1976. Detection of beta-lactamase production by gram-negative bacteria. J. Antibiot. (Tokyo) 29:662-664.
20. National Committee for Clinical Laboratory Standards. 2000. Performance Standards for Antimicrobial Susceptibility testing; 10th Informational Supplement (Aerobic Dilution) M100-S10. National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. Nordmann, P., and M. Guibert. 1998. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 42:128-131.
22. Paterson, D. L., N. Singh, T. Gayowski, and I. R. Marino. 1999. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: Implications for antibiotic choice for spontaneous bacterial peritonitis. Clin. Infect. Dis. 28:683-684.
23. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
24. Philippon, A., R. Labia, and G. A. Jacoby. 1989. Extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 33:1131-1136.
25. Rahal, J. J. 2000. Extended-spectrum beta-lactamases: How big is the problem? Clin. Microbiol. Infect. 2(Suppl. 2):2-6.
26. Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232.
27. Reisbig, M. D., and N. D. Hanson. 2002. The ACT-1 plasmid-encoded AmpC beta-lactamase is inducible: Detection in a complex beta-lactamase background. J. Antimicrob. Chemother. 49:557-560.
28. Sanders, C. C., and W. E. Sanders, Jr. 1992. β-lactam resistance in gram-negative bacteria: Global trends and clinical impact. Clin. Infect. Dis. 15:824-839.
29. Sanders, C. C., W. E. Sanders, Jr., and E. S. Moland. 1986. Characterization of β-lactamases in situ on polyacrylamide gels. Antimicrob. Agents Chemother. 30:951-952.
30. Sanders, C. C., and W. E. Sanders, Jr. 1979. Emergence of resistance to cefamandole: Possible role of cefoxitin-inducible β-lactamases. Antimicrob. Agents Chemother. 15:792-797.
31. Sanders, C. C., W. E. Sanders, Jr., K. S. Thomson, and J. P. laconis. 1989. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases. J. Antimicrob. Chemother. 24(Suppl. A):187-196.
32. Sanders, W. E., J. H. Tenney, and R. E. Kessler. 1996. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter spp. Clin. Infect. Dis. 23:454-461.
33. Sirot, D. 1995. Extended-spectrum plasmid-mediated β-lactamases. J. Antimicrob. Chemother. 36:19-34.
34. Tenover, F. C., M. J. Mohammed, T. S. Gorton, and Z. F. Dembek. 1999. Detection and reporting of organisms producing extended-spectrum β-lactamases: Survey of laboratories in Connecticut. J. Clin. Microbiol. 37:4065-4070.
35. Thomson, K. S., and C. C. Sanders. 1992. Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three-dimensional tests. Antimicrob. Agents Chemother. 36:1877-1882.
36. Thomson, K. S., C. C. Sanders, and E. S. Moland. 1999., Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacterfreundii, and Serratia marcescens. Antimicrob. Agents Chemother. 43:1393-1400.
37. Thomson, K. S., and E. Smith Moland. 2000. Version 2000: The new beta-lactamases of gram-negative bacteria at the dawn of the new millennium. Microbes Infect. 2:1225-1235.
38. Venezia, R. A., F. J. Scarano, K. E. Preston, L. M. Steele, T. P. Root, R. Limberger, W. Archinal, and M. A. Kacica. 1995. Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in Enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin. Infect. Dis. 21:915-923.